Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Amicus Therapeutics (FOLD) has announced its participation in two major investor conferences in June 2025. The company will present at the Jefferies Global Healthcare Conference in New York on June 4 at 11:40 a.m. ET and at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 10 at 2:00 p.m. ET. Both presentations will be accessible via live audio webcast through the investor relations section of Amicus' corporate website. Amicus Therapeutics is a global biotechnology company dedicated to developing and delivering innovative medicines for rare diseases, with a strong focus on patient care and advancing their pipeline of first- or best-in-class treatments.
Amicus Therapeutics (FOLD) ha annunciato la sua partecipazione a due importanti conferenze per investitori a giugno 2025. L'azienda presenterà alla Jefferies Global Healthcare Conference a New York il 4 giugno alle 11:40 ET e alla Goldman Sachs 46th Annual Global Healthcare Conference a Miami il 10 giugno alle 14:00 ET. Entrambe le presentazioni saranno accessibili in diretta audio streaming attraverso la sezione relazioni con gli investitori del sito web aziendale di Amicus. Amicus Therapeutics è un'azienda biotecnologica globale dedicata allo sviluppo e alla fornitura di farmaci innovativi per malattie rare, con un forte impegno nella cura dei pazienti e nell'avanzamento della loro pipeline di trattamenti di prima scelta o migliori nella loro categoria.
Amicus Therapeutics (FOLD) ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La compañía presentará en la Jefferies Global Healthcare Conference en Nueva York el 4 de junio a las 11:40 a.m. ET y en la Goldman Sachs 46th Annual Global Healthcare Conference en Miami el 10 de junio a las 2:00 p.m. ET. Ambas presentaciones estarán disponibles en transmisión de audio en vivo a través de la sección de relaciones con inversores del sitio web corporativo de Amicus. Amicus Therapeutics es una empresa biotecnológica global dedicada a desarrollar y ofrecer medicamentos innovadores para enfermedades raras, con un fuerte enfoque en el cuidado del paciente y en avanzar en su cartera de tratamientos de primera o mejor clase.
Amicus Therapeutics(FOLD)는 2025년 6월 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사는 6월 4일 오전 11시 40분(동부시간)에 뉴욕에서 열리는 Jefferies Global Healthcare Conference와 6월 10일 오후 2시(동부시간)에 마이애미에서 개최되는 Goldman Sachs 46th Annual Global Healthcare Conference에서 발표할 예정입니다. 두 발표 모두 Amicus 기업 웹사이트의 투자자 관계 섹션을 통해 실시간 오디오 웹캐스트로 시청할 수 있습니다. Amicus Therapeutics는 희귀 질환을 위한 혁신적인 의약품 개발 및 제공에 전념하는 글로벌 바이오테크 기업으로, 환자 치료와 선도적이거나 최고 수준의 치료제 개발에 중점을 두고 있습니다.
Amicus Therapeutics (FOLD) a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025. La société présentera lors de la Jefferies Global Healthcare Conference à New York le 4 juin à 11h40 ET et lors de la 46e conférence annuelle mondiale sur la santé de Goldman Sachs à Miami le 10 juin à 14h00 ET. Les deux présentations seront accessibles via une webdiffusion audio en direct dans la section relations investisseurs du site internet d'Amicus. Amicus Therapeutics est une entreprise biotechnologique mondiale dédiée au développement et à la fourniture de médicaments innovants pour les maladies rares, avec un fort engagement envers le soin des patients et l'avancement de leur pipeline de traitements de première classe ou les meilleurs de leur catégorie.
Amicus Therapeutics (FOLD) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am 4. Juni um 11:40 Uhr ET auf der Jefferies Global Healthcare Conference in New York und am 10. Juni um 14:00 Uhr ET auf der 46. jährlichen Global Healthcare Conference von Goldman Sachs in Miami präsentieren. Beide Präsentationen sind über einen Live-Audio-Webcast im Bereich Investor Relations auf der Unternehmenswebsite von Amicus zugänglich. Amicus Therapeutics ist ein globales Biotechnologieunternehmen, das sich der Entwicklung und Bereitstellung innovativer Medikamente für seltene Krankheiten widmet, mit einem starken Fokus auf Patientenversorgung und der Weiterentwicklung ihrer Pipeline mit erstklassigen oder besten Behandlungen.
Positive
- None.
Negative
- None.
PRINCETON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in June.
- Jefferies Global Healthcare Conference 2025 in New York, NY, on Wednesday, June 4, 2025, at 11:40 a.m. ET
- Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami, FL, on Tuesday, June 10, 2025, at 2:00 p.m. ET
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
Amicus Therapeut
NASDAQ:FOLD
FOLD Rankings
FOLD Latest News
FOLD Stock Data
1.93B
281.99M
0.83%
100.63%
5.06%
Biotechnology
Pharmaceutical Preparations
United States
PRINCETON